A case for lipid lowering? Response to Dr Paul Durrington.
作者信息
Yudkin J S
出版信息
Diabet Med. 2001 May;Suppl 3:11-2. doi: 10.1046/j.1464-5491.2001.00001-5.x.
Abstract
摘要
相似文献
1
A case for lipid lowering? Response to Dr Paul Durrington.
Diabet Med. 2001 May;Suppl 3:11-2. doi: 10.1046/j.1464-5491.2001.00001-5.x.
2
A case for lipid-lowering?是否需要降脂治疗？
Diabet Med. 2000 Sep;17 Suppl 2:4-5. doi: 10.1046/j.1464-5491.2000.00361-3.x.
3
Editorial: Lipid-lowering drugs after myocardial infarction.社论：心肌梗死后的降脂药物
Lancet. 1975 Mar 1;1(7905):501-2.
4
Lipids and diabetes mellitus: a review of therapeutic options.脂质与糖尿病：治疗选择综述
Curr Med Res Opin. 2002;18 Suppl 1:s58-74. doi: 10.1185/030079902125000246.
5
Lipid-lowering drug therapies: the evidence.降脂药物疗法：证据
Proc Nutr Soc. 2000 Aug;59(3):423-4. doi: 10.1017/s0029665100000513.
6
Evidence-based medicine and the selection of lipid-lowering therapy in type 2 diabetes.
Curr Diab Rep. 2012 Jun;12(3):221-3. doi: 10.1007/s11892-012-0266-7.
7
Options for the treatment of hyperlipidemia in Type 2 diabetes mellitus and hypothyroidism: lowering the cardiovascular risk.2型糖尿病合并甲状腺功能减退症患者高脂血症的治疗选择：降低心血管风险
Future Cardiol. 2011 Mar;7(2):137-44. doi: 10.2217/fca.10.126.
8
Use of lipid-lowering medication in patients with acute myocardial infarction (Worcester Heart Attack Study).急性心肌梗死患者使用降脂药物（伍斯特心脏病发作研究）
Am J Cardiol. 1997 Apr 15;79(8):1095-7. doi: 10.1016/s0002-9149(97)00051-9.
9
Lipid disorders in NIDDM: implications for treatment.
J Intern Med. 1998 Nov;244(5):361-70. doi: 10.1046/j.1365-2796.1998.00397.x.
10
[Lipids: diagnosis and therapy in type 2 diabetes].[脂质：2型糖尿病的诊断与治疗]
Wien Klin Wochenschr. 2012 Dec;124 Suppl 2:28-30. doi: 10.1007/s00508-012-0273-3.
Zotero 插件